Brain antibodies in the cortex and blood of people with schizophrenia and controls

作者：Glass L J; Sinclair D; Boerrigter D; Naude K; Fung S J; Brown D; Catts V S; Tooney P; O'Donnell M; Lenroot R; Galletly C; Liu D; Weickert T W; Weickert C Shannon^*

来源：Translational Psychiatry, 2017, 7(8): e1192.

DOI：10.1038/tp.2017.134

The immune system is implicated in the pathogenesis of schizophrenia, with elevated proinflammatory cytokine mRNAs found in the brains of similar to 40% of individuals with the disorder. However, it is not clear if antibodies (specifically immunoglobulin-gamma (IgG)) can be found in the brain of people with schizophrenia and if their abundance relates to brain inflammatory cytokine mRNA levels. Therefore, we investigated the localization and abundance of IgG in the frontal cortex of people with schizophrenia and controls, and the impact of proinflammatory cytokine status on IgG abundance in these groups. Brain IgGs were detected surrounding blood vessels in the human and non-human primate frontal cortex by immunohistochemistry. IgG levels did not differ significantly between schizophrenia cases and controls, or between schizophrenia cases in 'high' and 'low' proinflammatory cytokine subgroups. Consistent with the existence of IgG in the parenchyma of human brain, mRNA and protein of the IgG transporter (FcGRT) were present in the brain, and did not differ according to diagnosis or inflammatory status. Finally, brain-reactive antibody presence and abundance was investigated in the blood of living people. The plasma of living schizophrenia patients and healthy controls contained antibodies that displayed positive binding to Rhesus macaque cerebellar tissue, and the abundance of these antibodies was significantly lower in patients than controls. These findings suggest that antibodies in the brain and brain-reactive antibodies in the blood are present under normal circumstances.

• 出版日期2017-8-8